Kisspeptin-10 Research Applications and Study Design Notes

The Kisspeptin-10 research applications focus on the reproductive hormone axis. In this work the ten-residue peptide acts as a small, highly potent probe of the kisspeptin receptor. This note sums up common study settings. It also covers design points for preclinical and in vitro work. Read it strictly in a research context.

What is Kisspeptin-10 used for in research?

Kisspeptin-10 is used to study KISS1R signaling and how that signal reaches GnRH neurons and the gonadotropins. KISS1R is also called GPR54. Labs use the peptide in biochemical, cell-based, and animal studies. The study logic follows the Kisspeptin-10 mechanism of action. In that model, three tests recur at the receptor level:

• Gq/11 signaling
• Phospholipase C activity
• Calcium release inside the cell

The peptide sits upstream of a well-mapped circuit. So its uses fall into two groups. One group isolates the receptor in simple systems. The other watches the output of the whole axis in intact models. Both are described below.

How is Kisspeptin-10 used in reproductive hormone models?

A main use is studying how KISS1R turns on GnRH neurons. Labs then track the gonadotropin signals that follow, in animal and cell models. Kisspeptin-10 helps study the timing of the luteinizing hormone surge. It also helps study circuits tied to ovulation and the start of puberty signals. LH and FSH are common endpoints.

These models link a defined receptor input to the behavior of the whole axis. Labs often track how the LH surge before ovulation responds when the receptor is engaged. The peptide is used to probe how nerve circuits gate reproductive timing. It is not used to show effects in a whole body.

The peptide is also a common tool in studies of how the reproductive axis develops. Here the start of puberty signals is mapped against KISS1R activity. Loss-of-function changes in GPR54 are linked to hypogonadotropic hypogonadism, a state of low hormone output. So the pathway is a natural focus for one question. How does the axis switch from a quiet state to an active one? Kisspeptin-10 gives a defined stimulus to test that switch in animal models.

How is Kisspeptin-10 used in receptor and metabolic studies?

Kisspeptin-10 is used to test KISS1R pharmacology in engineered cells. Labs measure binding strength, second messengers, and how fast the receptor loses its response. These simple systems give clean data. They suit structure-activity work. They also let labs rank new ligands against a reference agonist.

Kisspeptin work also reaches beyond reproduction. Labs study where the pathway meets metabolic control. They ask how it may cross paths with circuits for energy balance. These studies aim to clarify receptor signaling between systems. They do not aim to show therapeutic effects. They need the same careful records used in receptor assays.

How does Kisspeptin-10 compare with Kisspeptin-54 and GnRH?

Kisspeptin-10 is the shortest fully active fragment. So it is often compared with the longer Kisspeptin-54 and with GnRH itself. These side-by-side designs look at three things:

• Differences in potency
• How long the signal lasts
• How the receptor is engaged

This helps labs separate what depends on peptide length from what depends on the shared receptor.

Comparisons also reach across the wider hormone and sexual-signaling group. Teams building larger panels often cite the melanocortin designs in the PT-141 research applications. They also cite the settings in the oxytocin research applications. These help frame how separate receptor systems are studied side by side.

What should a Kisspeptin-10 study design account for?

Kisspeptin-10 is a well-defined ten-residue peptide. That makes molar math simple. But the model still shapes the result. Three factors matter most: how much KISS1R is present, whether cells are nerve cells or engineered cells, and the reproductive state of an animal model. Record the cell line or model, receptor level, lot number, and purity. This keeps results comparable across studies.

• Note whether the system isolates the receptor (engineered cells) or keeps the full axis (intact model). The two answer different questions.
• Track molecular weight (about 1302.45 g/mol) and stated purity for exact working strengths.
• Log the lot number and certificate of analysis details for every dataset.

Preparation and storage practice is covered in the Kisspeptin-10 handling and reconstitution guide. Material with a certificate of analysis is listed on the Kisspeptin-10 product page.

Which specifications belong in study records?

Comparable studies depend on exact identity records. Kisspeptin-10 is defined by these values:

• Molecular formula: C63H83N17O14
• Molecular weight: about 1302.45 g/mol
• CAS number: 374675-21-5
• PubChem CID: 25240297
• Sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2

Put these in the methods section. This removes doubt when a study is later compared with work that used a different fragment.

The peptide appears in papers under several names. These include Metastin (45-54), KISS1 (112-121), and Kp-10. Pick one name within a project and note the others. This keeps searches and comparisons clean. It also stops one compound from being logged as two.

How can Kisspeptin-10 results be made reproducible?

The evidence base is preclinical. So comparisons across models work best when a few things stay fixed. Hold receptor setting, model state, and handling constant. Report them next to the LH, FSH, and receptor signal data. Steady records let other labs read kisspeptin data in a shared frame. They also reduce confusion when names like Metastin (45-54) or Kp-10 appear unevenly in the record.

Pair that identity record with a certificate of analysis and a lot number. This closes the loop between the material and the data. When receptor state, model, handling, and batch are all logged together, other labs can repeat the result. It stops being an isolated finding.

For research use only. Kisspeptin-10 is an investigational research peptide and is not approved for human or veterinary use. All applications described are preclinical and in vitro.